The PROMISE Initiative: Developing Reliable Living Evidence for Pediatric Medication Safety through the Trial Bank Project - Top-Institutions - MDSpire

The PROMISE Initiative: Developing Reliable Living Evidence for Pediatric Medication Safety through the Trial Bank Project

  • By

  • Chang Xu

  • Suhail A. Doi

  • Sunita Vohra

  • Luis Furuya-Kanamori

  • Yingxia Wang

  • Lijun Tang

  • Yuan Tian

  • Shiqi Fan

  • Zhen Peng

  • Evan Mayo-Wilson

  • Lifeng Lin

  • Haitao Chu

  • M. Hassan Murad

  • Tianqi Yu

  • Sheyu Li

  • Yaolong Chen

  • Su Golder

  • Yoon Loke

  • Justin Clark

  • Paul Glasziou

  • Liang Du

  • Houwen Lin

  • Zhichun Gu

  • February 21, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Pharmacology
    • Clinical Trial Research
    • Patient Safety

  • #2

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Clinical Informatics
    • Pediatric Pharmacology
    • Artificial Intelligence in Medicine

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Pediatric Clinical Research
    • Pharmacoepidemiology
    • Patient Safety

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Pediatric Pharmacology
    • Clinical Trial Methodology
    • Health Informatics

  • #5

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Clinical Pharmacology
    • Medication Safety
    • Clinical Trials

Original Source(s)

The PROMISE Initiative: Developing Reliable Living Evidence for Pediatric Medication Safety through the Trial Bank Project

  • by Chang Xu, Suhail A. Doi, Sunita Vohra, Luis Furuya-Kanamori, Yingxia Wang, Lijun Tang, Yuan Tian, Shiqi Fan, Zhen Peng, Evan Mayo-Wilson, Lifeng Lin, Haitao Chu, M. Hassan Murad, Tianqi Yu, Sheyu Li, Yaolong Chen, Su Golder, Yoon Loke, Justin Clark, Paul Glasziou, Liang Du, Houwen Lin, Zhichun Gu

  • February 21, 2026

Related Content

Perampanel use in pediatric autoimmune encephalitis-related seizures and epilepsy: a retrospective case series

Giant rapidly involuting congenital hemangioma in a neonate: a case report

Association between the albumin-to-lymphocyte ratio and short-term mortality in critically Ill pediatric patients: a retrospective cohort study and machine learning analysis